Tag Archives: infliximab
Inflammatory bowel disease as a paradoxical effect of anti-TNF alpha therapy
Anti-TNF alpha therapies are used in the treatment of different inflammatory conditions as inflammatory bowel disease (IBD). Specifically, IBD is a chronic disease characterized by inflammation of gastrointestinal tract, particularly of colon. It includes Crohn disease and
Are less expensive “biosimilar” drugs as effective at treating ankylosing spondylitis?
Ankylosing spondylitis (AS) is a type of arthritis caused by inflammation, in which the main symptom is back pain. When a substance called tumour necrosis factor (TNF) is over-active in the body, it causes inflammation and damage
Clinical studies ask: “Are less expensive ‘biosimilar’ drugs as effective and safe as current drugs?”
Several debilitating diseases caused by disorders in a patient’s immune system – often called ‘immune-mediated diseases’ – have become easier to treat in the last two decades following the discovery of drugs called ‘biologics’. Biologics act on